Larimar Therapeutics Inc. (LRMR)
NASDAQ: LRMR
· Real-Time Price · USD
4.00
-0.26 (-6.10%)
At close: Aug 15, 2025, 3:59 PM
4.02
0.63%
After-hours: Aug 15, 2025, 07:34 PM EDT
Larimar Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 21.13M | 33.22M | 35.07M | 32.31M | 110.13M | 26.75M | 38.72M | 94.32M | 111.52M | 26.82M | 86.05M | 19.74M | 62.56M | 70.1M | 71.53M | 70.63M | 62.19M |
Short-Term Investments | 136.4M | 150.24M | 168.64M | 193.75M | 117.17M | 60.04M | 56.87M | 9.88M | n/a | 91.6M | 38.65M | 35.19M | n/a | n/a | 6.5M | n/a | 19.25M |
Long-Term Investments | n/a | n/a | n/a | 1.34M | 13.05M | 1.34M | 1.34M | 1.34M | 1.34M | 1.34M | 1.34M | 1.34M | 1.34M | 1.34M | 1.34M | 1.34M | 1.34M |
Other Long-Term Assets | 1.19M | 1.2M | 1.96M | 636K | 678K | 659K | 634K | 644K | 632K | 638K | 643K | 649K | 668K | 669K | 671K | 672K | 750K |
Receivables | n/a | 1.05M | 943K | 751K | 1.08M | n/a | n/a | n/a | n/a | n/a | 114K | 237K | 323K | 208K | 219K | 67K | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -300K | -300K | n/a | n/a | n/a | n/a | -208K | n/a | n/a | n/a |
Other Current Assets | 383K | 517K | 371K | 309K | 344K | n/a | n/a | n/a | n/a | n/a | 362K | 366K | 293K | 279K | 115K | 193K | 107K |
Total Current Assets | 165.49M | 195.3M | 213.26M | 231.13M | 230.95M | 90.17M | 98.48M | 106.48M | 113.46M | 120.74M | 127.13M | 56.74M | 64.88M | 72.2M | 81.25M | 74.04M | 86.13M |
Property-Plant & Equipment | 3.5M | 3.72M | 3.81M | 4.06M | 3.52M | 3.76M | 3.5M | 3.25M | 3.47M | 3.69M | 3.91M | 4.12M | 4.34M | 4.46M | 4.67M | 4.88M | 4.8M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 4.69M | 4.92M | 5.76M | 6.03M | 17.25M | 5.76M | 5.47M | 5.24M | 5.44M | 5.67M | 5.89M | 6.11M | 6.34M | 6.46M | 6.68M | 6.89M | 6.89M |
Total Assets | 170.18M | 200.22M | 219.02M | 237.16M | 248.21M | 95.94M | 103.95M | 111.72M | 118.91M | 126.41M | 133.01M | 62.85M | 71.22M | 78.67M | 87.94M | 80.93M | 93.02M |
Account Payables | 2.27M | 2.42M | 1.69M | 2.92M | 1.92M | 1.28M | 756K | 2.34M | 695K | 1.69M | 849K | 425K | 2.42M | 1.66M | 1.77M | 1.46M | 3.23M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | 1.03M | 992K | n/a | n/a | 708K | 566K | 589K | n/a | 632K | 638K | 616K | n/a | 574K | 553K | 534K |
Other Current Liabilities | 19.86M | 18.68M | 10.17M | 14.72M | 9.31M | 5.02M | 2.73M | 2.75M | 5.57M | 6.36M | 5.87M | 5.02M | 4.67M | 5.49M | 6.43M | 4.27M | 3.62M |
Total Current Liabilities | 22.13M | 24.36M | 16.29M | 21.16M | 12.84M | 9.51M | 6.56M | 7.28M | 8.01M | 10.71M | 9.42M | 7.72M | 8.87M | 8.85M | 10.31M | 7.69M | 8.38M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 3.77M | 4.06M | 4.34M | 4.6M | 4.52M | 4.71M | 4.68M | 4.51M | 4.66M | 4.8M | 4.93M | 5.08M | 5.25M | 5.41M | 5.57M | 5.71M | 5.86M |
Total Liabilities | 25.9M | 28.41M | 20.62M | 25.76M | 17.36M | 14.21M | 11.24M | 11.79M | 12.67M | 15.5M | 14.35M | 12.8M | 14.12M | 14.25M | 15.87M | 13.41M | 14.23M |
Total Debt | 4.87M | 5.12M | 5.36M | 5.59M | 5.34M | 5.55M | 5.39M | 5.08M | 5.25M | 5.41M | 5.57M | 5.71M | 5.86M | 6M | 6.14M | 6.27M | 6.39M |
Common Stock | 64K | 64K | 64K | 64K | 64K | 43K | 43K | 43K | 43K | 43K | 43K | 18K | 18K | 18K | 18K | 15K | 15K |
Retained Earnings | -298.44M | -269.16M | -240.33M | -224.84M | -203.21M | -188.55M | -175.56M | -166.5M | -158.13M | -151.6M | -142.18M | -133.86M | -125.19M | -116.25M | -107.12M | -90.31M | -77.7M |
Comprehensive Income | n/a | 148K | 358K | -150K | -25K | 81K | 7K | 12K | -0.00 | -31K | -40K | -57K | -0.00 | -0.00 | n/a | 1K | 1K |
Shareholders Equity | 144.27M | 171.81M | 198.4M | 211.4M | 230.84M | 81.72M | 92.71M | 99.93M | 106.24M | 110.9M | 118.66M | 50.06M | 57.1M | 64.41M | 72.07M | 67.53M | 78.78M |
Total Investments | 136.4M | 150.24M | 168.64M | 195.09M | 130.22M | 61.38M | 56.87M | 9.88M | 1.34M | 91.6M | 38.65M | 35.19M | 1.34M | 1.34M | 6.5M | 1.34M | 19.25M |